{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:25:53Z","timestamp":1784132753639,"version":"3.55.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008233","name":"School of Medicine, Shanghai Jiao Tong University","doi-asserted-by":"publisher","award":["JYYQ001"],"award-info":[{"award-number":["JYYQ001"]}],"id":[{"id":"10.13039\/501100008233","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["12275178"],"award-info":[{"award-number":["12275178"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32071395"],"award-info":[{"award-number":["32071395"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81601623"],"award-info":[{"award-number":["81601623"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972530"],"award-info":[{"award-number":["81972530"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203038"],"award-info":[{"award-number":["82203038"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["19JC1410200"],"award-info":[{"award-number":["19JC1410200"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["20DZ2270800"],"award-info":[{"award-number":["20DZ2270800"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["201906235030"],"award-info":[{"award-number":["201906235030"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.actbio.2022.11.016","type":"journal-article","created":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T01:50:22Z","timestamp":1668563422000},"page":"538-553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["A miRNA-based gene therapy nanodrug synergistically enhances pro-inflammatory antitumor immunity against melanoma"],"prefix":"10.1016","volume":"155","author":[{"given":"Yawen","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haocheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengfang","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7483-9296","authenticated-orcid":false,"given":"Yilong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renbing","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kam W.","family":"Leong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8728-4568","authenticated-orcid":false,"given":"Jing","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2022.11.016_bib0001","doi-asserted-by":"crossref","first-page":"15003","DOI":"10.1038\/nrdp.2015.3","article-title":"Melanoma","volume":"1","author":"Schadendorf","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.actbio.2022.11.016_bib0002","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.5858\/2009-0441-RAR.1","article-title":"Ocular melanoma","volume":"134","author":"Laver","year":"2010","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.actbio.2022.11.016_bib0003","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-020-0158-0","article-title":"Uveal melanoma","volume":"6","author":"Jager","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.actbio.2022.11.016_bib0004","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/jamaophthalmol.2020.0531","article-title":"Incidence and survival of patients with conjunctival melanoma in Europe","volume":"138","author":"Virgili","year":"2020","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.actbio.2022.11.016_bib0005","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00262-019-02352-6","article-title":"Pembrolizumab as first-line treatment for metastatic uveal melanoma","volume":"68","author":"Rossi","year":"2019","journal-title":"Cancer Immunol., Immunotherapy: CII"},{"key":"10.1016\/j.actbio.2022.11.016_bib0006","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3390\/cancers11060815","article-title":"Aberrant microRNA expression and its implications for uveal melanoma metastasis","volume":"11","author":"Smit","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.actbio.2022.11.016_bib0007","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev-pathol-012513-104715","article-title":"MicroRNAs in cancer","volume":"9","author":"Di Leva","year":"2014","journal-title":"Ann. Rev. Pathol."},{"key":"10.1016\/j.actbio.2022.11.016_bib0008","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.actbio.2022.11.016_bib0009","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12943-020-1135-7","article-title":"Translation and functional roles of circular RNAs in human cancer","volume":"19","author":"Lei","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.actbio.2022.11.016_bib0010","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.exer.2019.01.004","article-title":"Identification of a nine-miRNA signature for the prognosis of uveal melanoma","volume":"180","author":"Xin","year":"2019","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.actbio.2022.11.016_bib0011","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1080\/15384047.2015.1046021","article-title":"miRNA profiling in vitreous humor, vitreal exosomes and serum from uveal melanoma patients: pathological and diagnostic implications","volume":"16","author":"Ragusa","year":"2015","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.actbio.2022.11.016_bib0012","doi-asserted-by":"crossref","first-page":"5447","DOI":"10.3390\/ijms20215447","article-title":"Conjunctival melanoma: genetic and epigenetic insights of a distinct type of melanoma","volume":"20","author":"Rossi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.actbio.2022.11.016_bib0013","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13046-018-0679-5","article-title":"The miR-181 family promotes cell cycle by targeting CTDSPL, a phosphatase-like tumor suppressor in uveal melanoma","volume":"37","author":"Zhang","year":"2018","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"key":"10.1016\/j.actbio.2022.11.016_bib0014","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00018-020-03612-w","article-title":"Emerging roles of microRNAs and their implications in uveal melanoma","volume":"78","author":"Yang","year":"2021","journal-title":"Cell. Mol. Life Sci.: CMLS"},{"key":"10.1016\/j.actbio.2022.11.016_bib0015","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12943-017-0591-1","article-title":"CD73\/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer","volume":"16","author":"Zhu","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.actbio.2022.11.016_bib0016","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1038\/s41418-018-0103-x","article-title":"A p53\/miR-30a\/ZEB2 axis controls triple negative breast cancer aggressiveness","volume":"25","author":"di Gennaro","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.actbio.2022.11.016_bib0017","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13046-020-01600-3","article-title":"MicroRNA-30a-5p(me): a novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma in tissue and urine samples","volume":"39","author":"Outeiro-Pinho","year":"2020","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"key":"10.1016\/j.actbio.2022.11.016_bib0018","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.canlet.2017.04.034","article-title":"miR-30a-5p suppresses breast tumor growth and metastasis through inhibition of LDHA-mediated Warburg effect","volume":"400","author":"Li","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.actbio.2022.11.016_bib0019","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1016\/j.ymthe.2018.09.006","article-title":"miR-30 family reduction maintains self-renewal and promotes tumorigenesis in NSCLC-initiating cells by targeting oncogene TM4SF1","volume":"26","author":"Ma","year":"2018","journal-title":"Mol. Therapy : J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.actbio.2022.11.016_bib0020","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1158\/1078-0432.CCR-18-0716","article-title":"Integrated genomic and functional microRNA analysis identifies miR-30-5p as a tumor suppressor and potential therapeutic nanomedicine in head and neck cancer","volume":"25","author":"Saleh","year":"2019","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.actbio.2022.11.016_bib0021","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41467-017-00411-z","article-title":"Platelets reduce anoikis and promote metastasis by activating YAP1 signaling","volume":"8","author":"Haemmerle","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.actbio.2022.11.016_bib0022","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/pros.23979","article-title":"miR-30a inhibits androgen-independent growth of prostate cancer via targeting MYBL2, FOXD1, and SOX4","volume":"80","author":"Li","year":"2020","journal-title":"Prostate"},{"key":"10.1016\/j.actbio.2022.11.016_bib0023","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/s10120-020-01052-w","article-title":"microRNA-30a arbitrates intestinal-type early gastric carcinogenesis by directly targeting ITGA2","volume":"23","author":"Min","year":"2020","journal-title":"Gastr. Cancer: Off. J. Int. Gastr. Cancer Assoc. Japan. Gastr. Cancer Assoc."},{"key":"10.1016\/j.actbio.2022.11.016_bib0024","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1476-4598-12-61","article-title":"BCL11A overexpression predicts survival and relapse in non-small cell lung cancer and is modulated by microRNA-30a and gene amplification","volume":"12","author":"Jiang","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.actbio.2022.11.016_bib0025","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.canlet.2017.10.012","article-title":"MicroRNA-30a suppresses autophagy-mediated anoikis resistance and metastasis in hepatocellular carcinoma","volume":"412","author":"Fu","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.actbio.2022.11.016_bib0026","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s10637-016-0407-y","article-title":"Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors","volume":"35","author":"Beg","year":"2017","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.actbio.2022.11.016_bib0027","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S1470-2045(17)30621-6","article-title":"Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study","volume":"18","author":"van Zandwijk","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.actbio.2022.11.016_bib0028","article-title":"Nanomaterials for cancer precision medicine","volume":"30","author":"Wang","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.actbio.2022.11.016_bib0029","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1172\/JCI81130","article-title":"Versatile roles of extracellular vesicles in cancer","volume":"126","author":"Kosaka","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.actbio.2022.11.016_bib0030","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.biomaterials.2012.10.023","article-title":"A gold nanoparticle platform for the delivery of functional microRNAs into cancer cells","volume":"34","author":"Ghosh","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2022.11.016_bib0031","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.0c05722","article-title":"Reactive oxygen species activatable heterodimeric prodrug as tumor-selective nanotheranostics","author":"Jiang","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2022.11.016_bib0032","doi-asserted-by":"crossref","first-page":"8576","DOI":"10.1039\/C5CS00541H","article-title":"In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles","volume":"44","author":"Arami","year":"2015","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.actbio.2022.11.016_bib0033","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.addr.2018.12.007","article-title":"Superparamagnetic iron oxides as MPI tracers: a primer and review of early applications","volume":"138","author":"Bulte","year":"2019","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.actbio.2022.11.016_bib0034","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.7150\/thno.42564","article-title":"Multifunctional magnetic iron oxide nanoparticles: an advanced platform for cancer theranostics","volume":"10","author":"Zhao","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.actbio.2022.11.016_bib0035","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1039\/C9TB02521A","article-title":"Rituximab conjugated iron oxide nanoparticles for targeted imaging and enhanced treatment against CD20-positive lymphoma","volume":"8","author":"Song","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.actbio.2022.11.016_bib0036","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/nnano.2016.168","article-title":"Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues","volume":"11","author":"Zanganeh","year":"2016","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.actbio.2022.11.016_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.693709","article-title":"The use of iron oxide nanoparticles to reprogram macrophage responses and the immunological tumor microenvironment","volume":"12","author":"Mulens-Arias","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actbio.2022.11.016_bib0038","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1039\/B607886A","article-title":"Amino-functionalization of large-pore mesoscopically ordered silica by a one-step hyperbranching polymerization of a surface-grown polyethyleneimine","author":"Rosenholm","year":"2006","journal-title":"Chem. Commun."},{"key":"10.1016\/j.actbio.2022.11.016_bib0039","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1021\/nn103213y","article-title":"Mesoporous biocompatible and acid-degradable magnetic colloidal nanocrystal clusters with sustainable stability and high hydrophobic drug loading capacity","volume":"5","author":"Luo","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2022.11.016_bib0040","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jconrel.2020.08.012","article-title":"Controlled anti-cancer drug release through advanced nano-drug delivery systems: Static and dynamic targeting strategies","volume":"327","author":"Moradi Kashkooli","year":"2020","journal-title":"J. Control. Release : Off. J. Control. Release Soc."},{"key":"10.1016\/j.actbio.2022.11.016_bib0041","article-title":"Cyclodextrin based unimolecular micelles with targeting and biocleavable abilities as chemotherapeutic carrier to overcome drug resistance","volume":"105","author":"Li","year":"2019","journal-title":"Mater. Sci. Eng. C, Mater. Biol. Applic."},{"key":"10.1016\/j.actbio.2022.11.016_bib0042","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1021\/cr300358b","article-title":"Disulfide-cleavage-triggered chemosensors and their biological applications","volume":"113","author":"Lee","year":"2013","journal-title":"Chem. Rev."},{"key":"10.1016\/j.actbio.2022.11.016_bib0043","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1083\/jcb.201804161","article-title":"Glutathione metabolism in cancer progression and treatment resistance","volume":"217","author":"Bansal","year":"2018","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.actbio.2022.11.016_bib0044","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cell.2009.05.045","article-title":"CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells","volume":"138","author":"Majeti","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.actbio.2022.11.016_bib0045","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12943-020-01173-x","article-title":"Verification of EZH2 as a druggable target in metastatic uveal melanoma","volume":"19","author":"Jin","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.actbio.2022.11.016_bib0046","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1039\/c0py00144a","article-title":"Selenium-containing block copolymers and their oxidation-responsive aggregates","volume":"1","author":"Ma","year":"2010","journal-title":"Polym. Chem."},{"key":"10.1016\/j.actbio.2022.11.016_bib0047","first-page":"11","article-title":"Aberrant microRNA expression and its implications for uveal melanoma metastasis","author":"Smit","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.actbio.2022.11.016_bib0048","doi-asserted-by":"crossref","first-page":"5259","DOI":"10.1158\/0008-5472.CAN-17-3058","article-title":"miRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis-associated genes","volume":"78","author":"Croset","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.actbio.2022.11.016_bib0049","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.addr.2019.04.008","article-title":"Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine","volume":"143","author":"Donahue","year":"2019","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.actbio.2022.11.016_bib0050","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41467-020-14713-2","article-title":"Pan-cancer analysis reveals cooperativity of both strands of microRNA that regulate tumorigenesis and patient survival","volume":"11","author":"Mitra","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.actbio.2022.11.016_bib0051","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000003647","article-title":"Genomewide expression profiling identifies a novel miRNA-based signature for the detection of peritoneal metastasis in patients with gastric cancer","volume":"274","author":"Shimura","year":"2021","journal-title":"Ann. Surg."},{"key":"10.1016\/j.actbio.2022.11.016_bib0052","doi-asserted-by":"crossref","first-page":"417","DOI":"10.5483\/BMBRep.2014.47.8.109","article-title":"MicroRNA-directed cleavage of targets: mechanism and experimental approaches","volume":"47","author":"Park","year":"2014","journal-title":"BMB Rep."},{"key":"10.1016\/j.actbio.2022.11.016_bib0053","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41419-018-0444-x","article-title":"MicroRNA-30a-5p inhibits gallbladder cancer cell proliferation, migration and metastasis by targeting E2F7","volume":"9","author":"Ye","year":"2018","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.actbio.2022.11.016_bib0054","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.18632\/oncotarget.23529","article-title":"miR-30a suppresses lung cancer progression by targeting SIRT1","volume":"9","author":"Guan","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.actbio.2022.11.016_bib0055","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/jnr.23637","article-title":"Micro-RNA-30a regulates ischemia-induced cell death by targeting heat shock protein HSPA5 in primary cultured cortical neurons and mouse brain after stroke","volume":"93","author":"Wang","year":"2015","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.actbio.2022.11.016_bib0056","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrc2696","article-title":"Emerging roles of E2Fs in cancer: an exit from cell cycle control","volume":"9","author":"Chen","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.actbio.2022.11.016_bib0057","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s13046-018-0927-8","article-title":"MicroRNA-302a\/d inhibits the self-renewal capability and cell cycle entry of liver cancer stem cells by targeting the E2F7\/AKT axis","volume":"37","author":"Ma","year":"2018","journal-title":"J. Exp. Clin. Cancer Res.: CR"},{"key":"10.1016\/j.actbio.2022.11.016_bib0058","doi-asserted-by":"crossref","first-page":"e413","DOI":"10.1038\/cddis.2012.151","article-title":"The microRNA-26a target E2F7 sustains cell proliferation and inhibits monocytic differentiation of acute myeloid leukemia cells","volume":"3","author":"Salvatori","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.actbio.2022.11.016_bib0059","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/hep.31259","article-title":"E2F7 is a potent inhibitor of liver tumor growth in adult mice","volume":"73","author":"Moreno","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.actbio.2022.11.016_bib0060","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1158\/0008-5472.CAN-08-2725","article-title":"E2F7 can regulate proliferation, differentiation, and apoptotic responses in human keratinocytes: implications for cutaneous squamous cell carcinoma formation","volume":"69","author":"Endo-Munoz","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.actbio.2022.11.016_bib0061","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/onc.2016.251","article-title":"Synergistic functions of E2F7 and E2F8 are critical to suppress stress-induced skin cancer","volume":"36","author":"Thurlings","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.actbio.2022.11.016_bib0062","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3892\/or.2020.7659","article-title":"E2F7, regulated by miR30c, inhibits apoptosis and promotes cell cycle of prostate cancer cells","volume":"44","author":"Wang","year":"2020","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.actbio.2022.11.016_bib0063","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/34112","article-title":"A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD","volume":"391","author":"Enari","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.actbio.2022.11.016_bib0064","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.1158\/1078-0432.CCR-10-3420","article-title":"MRI of tumor-associated macrophages with clinically applicable iron oxide nanoparticles","volume":"17","author":"Daldrup-Link","year":"2011","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.actbio.2022.11.016_bib0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.biomaterials.2019.02.026","article-title":"Iron oxide nanoparticles promote macrophage autophagy and inflammatory response through activation of toll-like Receptor-4 signaling","volume":"203","author":"Jin","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2022.11.016_bib0066","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.addr.2017.09.007","article-title":"In vitro and ex vivo models to study drug delivery barriers in the posterior segment of the eye","volume":"126","author":"Peynshaert","year":"2018","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.actbio.2022.11.016_bib0067","doi-asserted-by":"crossref","first-page":"17817","DOI":"10.1073\/pnas.0908561106","article-title":"An experimental platform for systemic drug delivery to the retina","volume":"106","author":"Campbell","year":"2009","journal-title":"Proc. Nat. Acad. Sci. USA"}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706122007437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706122007437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:02:18Z","timestamp":1761674538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706122007437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":67,"alternative-id":["S1742706122007437"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2022.11.016","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A miRNA-based gene therapy nanodrug synergistically enhances pro-inflammatory antitumor immunity against melanoma","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2022.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}